SPERO THERAPEUTICS INC (SPRO)
US84833T1034 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 22.81M | -46.42M | -89.76M | -78.28M | -60.93M | |||
| Depreciation Amortization | 367.00K | 870.00K | 650.00K | 760.00K | 750.00K | |||
| Change In Working Capital | -70.38M | 22.09M | 12.86M | -13.46M | 6.78M | |||
| Taxes Paid | 2.21M | N/A | N/A | N/A | N/A | |||
| Other non cash items | 14.21M | 15.73M | 11.90M | 5.11M | 3.38M | |||
| OPERATING CASH FLOW | -32.99M | -7.73M | -64.35M | -85.87M | -50.02M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | -160.00K | -310.00K | |||
| Other Investing Activity | 0.00 | 33.81M | 7.67M | 10.63M | 29.84M | |||
| INVESTING CASH FLOW | 0.00 | 33.81M | 7.67M | 10.47M | 29.53M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | -54.49M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 221.00K | 24.93M | 36.82M | 131.83M | 16.30M | |||
| Other Financing Activity | N/A | 0.00 | 47.23M | -950.00K | -160.00K | |||
| FINANCING CASH FLOW | 221.00K | -29.55M | 84.05M | 130.88M | 16.14M | |||
| CHANGE IN CASH | -32.77M | -3.47M | 27.37M | 55.48M | -4.35M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -32.99M | -7.73M | -64.35M | -85.87M | -50.02M | |||
| Capital Expenditure | N/A | N/A | N/A | -160.00K | -310.00K | |||
| FREE CASH FLOW | -32.99M | -7.73M | -64.35M | -86.03M | -50.33M | |||
All data in USD